Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine + dexamethasone intercostal nerve block for post-thoracoscopic analgesia
ChiCTR2600123213Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Area under the curve of NRS pain intensity after activity from 36 to 60 hours postoperatively. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600123213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123213.